Latest Financials News

Asian Battery Metals PLC reports outstanding metallurgical test results from its Oval Cu-Ni-PGE project in Mongolia, confirming high copper recoveries of up to 95% with a simple flotation process and no penalty elements. Nickel concentrate optimization is underway, supporting the project's development trajectory.

Lefroy Exploration has received a second $0.75 million cash advance from BML Ventures, reinforcing its funding position ahead of key production milestones at the Lucky Strike Gold Project.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.

Torque Metals has raised $16.2 million through a $15 million placement and early option exercises, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

NTAW Holdings has secured an extension of its financial covenant waiver with Commonwealth Bank of Australia until March 2026, while continuing to reduce its borrowing facility.

Credit Corp Group has submitted a non-binding indicative proposal to acquire Humm Group, marking a potential consolidation in the consumer finance sector. The proposal remains conditional as due diligence information is yet to be provided.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Humm Group has received a shareholder notice to remove key directors alongside a non-binding acquisition proposal from Credit Corp, signaling potential major changes ahead.

Neurotech International has locked in $4 million through a share placement to advance its promising paediatric neurological drug, NTI164. The raise, supported by both new and existing investors including company directors, aims to fund critical clinical and regulatory milestones.